Evidence map›Paper›PMID 37313176›Full record

ArticleHeliyon2023

Machine learning and physical based modeling for cardiac hypertrophy.

Bogdan Milićević, Miljan Milošević, Vladimir Simić, Andrej Preveden, Lazar Velicki, Đorđe Jakovljević, Zoran Bosnić, Matej Pičulin, Bojan Žunkovič, Miloš Kojić and 1 more

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bogdan MilićevićFaculty of Engineering, University of Kragujevac, Kragujevac 34000, Serbia.
Miljan MiloševićBioengineering Research and Development Center (BioIRC), Kragujevac 34000, Serbia.
Vladimir SimićBioengineering Research and Development Center (BioIRC), Kragujevac 34000, Serbia.
Andrej PrevedenFaculty of Medicine, University of Novi Sad, Serbia and Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia.
Lazar VelickiFaculty of Medicine, University of Novi Sad, Serbia and Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia.
Đorđe JakovljevićTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Zoran BosnićUniversity of Ljubljana, Faculty of Computer and Information Science, Večna Pot 113, Ljubljana, Slovenia.
Matej PičulinUniversity of Ljubljana, Faculty of Computer and Information Science, Večna Pot 113, Ljubljana, Slovenia.
Bojan ŽunkovičUniversity of Ljubljana, Faculty of Computer and Information Science, Večna Pot 113, Ljubljana, Slovenia.
Miloš KojićBioengineering Research and Development Center (BioIRC), Kragujevac 34000, Serbia.
Nenad FilipovićFaculty of Engineering, University of Kragujevac, Kragujevac 34000, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: Predicting the long-term expansion and remodeling of the left ventricle in patients is challenging task but it has the potential to be clinically very useful. Methods: In our study, we present machine learning models based on random forests, gradient boosting, and neural networks, used to track cardiac hypertrophy. We collected data from multiple patients, and then the model was trained using the patient's medical history and present level of cardiac health. We also demonstrate a physical-based model, using the finite element procedure to simulate the development of cardiac hypertrophy. Results: Our models were used to forecast the evolution of hypertrophy over six years. The machine learning model and finite element model provided similar results. Conclusions: The finite element model is much slower, but it's more accurate compared to the machine learning model since it's based on physical laws guiding the hypertrophy process. On the other hand, the machine learning model is fast but the results can be less trustworthy in some cases. Both of our models, enable us to monitor the development of the disease. Because of its speed machine learning model is more likely to be used in clinical practice. Further improvements to our machine learning model could be achieved by collecting data from finite element simulations, adding them to the dataset, and retraining the model. This can result in a fast and more accurate model combining the advantages of physical-based and machine learning modeling.

Indexed as

Cardiac hypertrophyDisease progress trackingFinite element analysisLeft ventricle modeMachine learning

Identifiers

PMID37313176
PMCPMC10258386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.